Risedronate
Risedronate sodium delayed-release tablets are bisphosphonate in a delayed-release formulation and is indicated for treatment of postmenopausal osteoporosis (1.1) Limitations of Use Optimal duration of use has not been determined.
United States
$718
per month
India
$33
per month
You save
−95%save $685/mo · 95% cheaper
284.1K US scripts/yr$194.5M potential annual savings$203.9M US spend/yr
Drag to rotate · 3D structureC7H11NO7P2
SMILES: C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
Compare the price
US price$718per month
India price$33per month
You save$68595% less
Based on 30 units per month. US $23.92 vs India $1.10 per unit.
Total over 1 periodSave $685$718 → $33
The bigger picture
Risedronate is filled about 284.1K times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$203.9M
If sourced from India
$9.4M
Potential annual savings
$194.5M
−95%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.